Literature DB >> 29105494

Causes of Death in Different Subtypes of Ischemic and Hemorrhagic Stroke.

Chi-Hung Liu1, Jr-Rung Lin2, Chia-Wei Liou3, Jiann-Der Lee4, Tsung-I Peng5, Meng Lee4, Tsong-Hai Lee1.   

Abstract

Causes of death in both ischemic stroke (IS) and hemorrhagic stroke (HS) subtypes are not comprehensively studied. Between 2008 and 2011, we enrolled 11 215 first-ever stroke patients from the Stroke Registry of Chang-Gung Healthcare System and linked these data to the national death registry. The main causes of death in each stroke subtype were assessed. Patients with HS had higher overall mortality than IS (32.0% vs 18.1%, P < .001). In IS subtypes, large-artery atherosclerosis plus cardioembolism had the worst mortality (40.7%, P < .001). Stroke was the leading cause of death in both IS and HS within the first year. Stroke remained the major cause of death in HS, but cancer was the leading cause of death in IS after the first year. After excluding the patients with previous cancer history, cancer was still an important cause of death in IS and HS, particularly in the IS subtypes of small vessel occlusion, stroke of undetermined etiology, and transient ischemic attack.

Entities:  

Keywords:  cancer; cardiac disease; cause of death; mortality; stroke

Mesh:

Year:  2017        PMID: 29105494     DOI: 10.1177/0003319717738687

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  9 in total

1.  Cause-Specific Mortality as a Sequalae of Perioperative Stroke Following Cardiac and Vascular Surgery.

Authors:  Nathan J Reinert; Bansri M Patel; Qasem N AlShaer; Liwen Wu; Stephen Wisniewski; Eric S Hager; Mitchell R Dyer; Parthasarathy D Thirumala
Journal:  Neurologist       Date:  2021-11-30       Impact factor: 1.398

2.  Identification of Metabolomics Biomarkers in Extracranial Carotid Artery Stenosis.

Authors:  Chia-Ni Lin; Kai-Cheng Hsu; Kuo-Lun Huang; Wen-Cheng Huang; Yi-Lun Hung; Tsong-Hai Lee
Journal:  Cells       Date:  2022-09-27       Impact factor: 7.666

3.  Resuming anticoagulation in patients with atrial fibrillation experiencing intracranial hemorrhage.

Authors:  Victor Chien-Chia Wu; Yi-Chun Huang; Shao-Wei Chen; Chi-Hung Liu; Chun-Wei Chang; Ching-Chang Chen; Shang-Hung Chang; Ming-Shyan Lin; Tsong-Hai Lee; Mien-Cheng Chen; I-Chang Hsieh; Pao-Hsien Chu; Yu-Sheng Lin
Journal:  Medicine (Baltimore)       Date:  2021-08-13       Impact factor: 1.817

Review 4.  Registry-based stroke research in Taiwan: past and future.

Authors:  Cheng-Yang Hsieh; Darren Philbert Wu; Sheng-Feng Sung
Journal:  Epidemiol Health       Date:  2018-02-04

5.  Hypertension Among Hemorrhagic Stroke Patients in Northeast China: A Population-Based Study 2017-2019.

Authors:  Haoran Dong; Shuang Liu; Li Jing; Mengyuan Tian; Jinglun Sun; Yanmin Pang; Liying Xing; Yingying Xu
Journal:  Med Sci Monit       Date:  2020-12-30

6.  Association of CYP26C1 Promoter Hypomethylation with Small Vessel Occlusion in Korean Subjects.

Authors:  Eun-Ji Lee; Myung-Sunny Kim; Nam-Hui Yim; Min Ho Cha
Journal:  Genes (Basel)       Date:  2021-10-14       Impact factor: 4.096

7.  Radiographic Predictors of Shunt Dependency in Intracranial Hemorrhage With Intraventricular Extension.

Authors:  James Brazdzionis; Paras Savla; Stacey Podkovik; Ira Bowen; Emilio C Tayag; Michael Schiraldi; Dan E Miulli
Journal:  Cureus       Date:  2022-08-25

8.  Computational Fluid Dynamics as an Engineering Tool for the Reconstruction of Hemodynamics after Carotid Artery Stenosis Operation: A Case Study.

Authors:  Andrzej Polanczyk; Michal Podgorski; Tomasz Wozniak; Ludomir Stefanczyk; Michal Strzelecki
Journal:  Medicina (Kaunas)       Date:  2018-06-01       Impact factor: 2.430

9.  Choices for long-term hypertensive control in patients after first-ever hemorrhagic stroke: a nationwide cohort study.

Authors:  Chi-Hung Liu; Yu-Sheng Lin; Ching-Chi Chi; Chia-Wei Liou; Jiann-Der Lee; Tsung-I Peng; Tsong-Hai Lee
Journal:  Ther Adv Neurol Disord       Date:  2018-09-28       Impact factor: 6.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.